Fig 1.
AMI: acute myocardial infraction, KAMIR-NIH: Korean Acute Myocardial Infarction Registry National Institutes of Health, PCI: percutaneous coronary intervention.
Table 1.
Clinical characteristics of the clopidogrel and ticagrelor or prasugrel groups.
Table 2.
Coronary angiographic findings and procedural characteristics of the clopidogrel and ticagrelor or prasugrel groups.
Table 3.
Complications during hospitalization of the clopidogrel and ticagrelor or prasugrel groups.
Table 4.
Clinical outcomes in the clopidogrel and ticagrelor or prasugrel groups during a 3-year follow-up period.
Fig 2.
Kaplan–Meier curve for net adverse cardiac event (NACE) in clopidogerl group and ticagrelor or prasugrel group.
Table 5.
Cox regression analysis for independent predictors of 3-year NACE in patients with acute myocardial infarction.
Fig 3.
Forest plot of exploratory subgroup analysis between clopidogrel group and ticagrelor or prasugrel group for NACE (net adverse cardiac event).
CI: confidence interval, LV: left ventricular.